In addition, inhibition of MAPKAP2 and MAPKAP3 in obese, insulin-resistant mice has been shown to result in improved metabolism40, in line with the association between upregulation of PLAGL1 and the development of TNDM. This evidence concerns the gene PLAGL1 and Insulin resistance.